Conversations You Want About Corona Virus Disease (COVID-19) (COVID-19)

BECAUSE YOU MATTER: Conversations You Want About COVID-19

Web-enabled virtual topical guide: develop virtual conversations for each concern and intensity level

Study Overview

• Status: Terminated
• Conditions: Covid19

Detailed Description

Study will pilot test the virtual topical discussion guide with diverse health care professions and community members to confirm it is clear, relevant, understandable, and culturally appropriate

• Study Type: Observational
• Enrollment (Actual): 30

Contacts and Locations

Study Locations

• United States
  • North Carolina
    • Winston-Salem, North Carolina, United States, 27157
      • Wake Forest Health Sciences

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes

• Sampling Method: Probability Sample

Study Population

Diverse health care professions and community members

Description

Inclusion Criteria:

• greater than or equal to 18 years of age
• English or Spanish speaking only

Exclusion Criteria:

• less than 18 years of age
• not English or Spanish speaking

Study Plan

How is the study designed?

Design Details

• Observational Models: Case-Only
• Time Perspectives: Prospective

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort
Virtual topical discussion guide; Study will pilot test this virtual topical discussion guide to assess feasibility and acceptability by diverse patient populations.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Time spent with the guide	Time spent with the guide	Week 4
Number of clinics viewed in the guide	Number of clinics viewed in the guide	Week 4
Number of content areas accessed	Number of content areas accessed	Week 4
Time spent with each content area	Time spent with each content area	Week 4
Helpfulness of Tool	How helpful was this tool in your decision-making, ranging from 1 not at all helpful to 5 incredibly helpful	Week 4
Number of Subjects saving responses	Individuals will have the ability to send their guide responses to themselves for later use	Week 4

Collaborators and Investigators

• Sponsor: Wake Forest University Health Sciences
• Investigators: Principal Investigator: Katherine A Poehling, MD, Wake Forest Health Sciences

Study record dates

Study Major Dates

• Study Start (Actual): March 9, 2022
• Primary Completion (Actual): May 15, 2023
• Study Completion (Actual): May 15, 2023

Study Registration Dates

• First Submitted: January 11, 2022
• First Submitted That Met QC Criteria: January 11, 2022
• First Posted (Actual): January 13, 2022

Study Record Updates

• Last Update Posted (Actual): June 1, 2026
• Last Update Submitted That Met QC Criteria: May 27, 2026
• Last Verified: May 1, 2026

More Information

Terms related to this study

• Keywords: Vaccines
• Additional Relevant MeSH Terms: Respiratory Tract Infections; Infections; RNA Virus Infections; Virus Diseases; Respiratory Tract Diseases; Lung Diseases; Pneumonia, Viral; Pneumonia; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; COVID-19
• Other Study ID Numbers: IRB00075790

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No